June 17th 2021, 4:00pm
A woman with stage 4 ovarian cancer discusses the importance of having compassion for other people, because you never know what they may be dealing with.
June 14th 2021, 9:03pm
CNN’s chief international anchor announced her ovarian cancer diagnosis live on-air today, which she wants everyone to use as a call to arms for all people to undergo cancer screening.
June 9th 2021, 6:00pm
Maintenance treatment with Lynparza plus Avastin over Avastin alone provided a certain group of patients with ovarian cancer a substantial survival benefit.
June 5th 2021, 5:00pm
Progression-free survival improved with Zejula compared with placebo in patients with BRCA-mutated ovarian cancer with no new safety signals.
June 1st 2021, 6:00pm
Each month, we take a look back at the most popular CURE® stories. Here are the top five stories for May 2021.
May 27th 2021, 6:00pm
Evidence from a phase 3 trial does not support the addition of Tecentriq to a specific chemotherapy regimen with Avastin for patients with newly diagnosed stage 3 or 4 ovarian cancer.
May 25th 2021, 9:00pm
This maintenance therapy approach approved progression-free survival without a major impact on quality of life in patients with newly diagnosed ovarian cancer with a BRCA mutation who recently responded to chemotherapy.
May 25th 2021, 1:00pm
Vulnerable older patients with advanced ovarian cancer do not respond well to carboplatin treatment alone compared to a combination with paclitaxel.
May 13th 2021, 3:00pm
In this episode of the “CURE® Talks Cancer” podcast, Maria Ciesla, an ovarian cancer survivor, and her daughter Alex Cornwell discuss Ciesla’s cancer journey and how it led them to do genetic testing that revealed they were both carriers of the BRCA1 mutation.
May 8th 2021, 3:00pm
Today is World Ovarian Cancer Day, and in honor of this day that was created in 2013 to raise awareness about the disease, CURE® is rounding up the latest news and updates in this cancer space.
A Milkshake and Metastatic Cancer
Fighting Hard for Patients with Fibrolamellar Carcinoma
Masking in a ‘Post-Pandemic’ World
A Guardian Angel Among Doctors
